These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10432766)

  • 1. Clopidogrel: a new antiplatelet agent.
    Feret B
    Conn Med; 1999 Jun; 63(6):331-3. PubMed ID: 10432766
    [No Abstract]   [Full Text] [Related]  

  • 2. Using clopidogrel bisulfate: a new antiplatelet drug.
    Pfister SM
    Nurse Pract; 1999 Sep; 24(9):100-1, 105-8, 110. PubMed ID: 10507077
    [No Abstract]   [Full Text] [Related]  

  • 3. Clopidogrel: a new antiplatelet drug.
    Lerner RG; Frishman WH; Mohan KT
    Heart Dis; 2000; 2(2):168-73. PubMed ID: 11728254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet ADP receptor antagonists: ticlopidine and clopidogrel.
    Jacobson AK
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):55-64. PubMed ID: 15171957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes.
    Rodgers JE; Steinhubl SR
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):507-21. PubMed ID: 15030250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel.
    Orford JL; Fasseas P; Brosh D; Berger PB
    Indian Heart J; 2001; 53(6):788-91. PubMed ID: 11838939
    [No Abstract]   [Full Text] [Related]  

  • 7. Variability of response to clopidogrel: possible mechanisms and clinical implications.
    Nguyen T; Frishman WH; Nawarskas J; Lerner RG
    Cardiol Rev; 2006; 14(3):136-42. PubMed ID: 16628022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Routine platelet aggregation inhibition not useful when using acetylsalicylic acid or clopidogrel].
    Kramer MC; Nieuwland R; Sturk A; de Winter RJ
    Ned Tijdschr Geneeskd; 2009 Jan; 153(5):190-5. PubMed ID: 19256247
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
    David JL; Limet R
    Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?
    Black C; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):277-303. PubMed ID: 11770173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clopidogrel. Actions, pharmacokinetics, clinical studies].
    Wunderlich H; Beer J; Allgaier C
    Med Monatsschr Pharm; 2002 Dec; 25(12):425-9. PubMed ID: 12522913
    [No Abstract]   [Full Text] [Related]  

  • 12. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 13. Clopidogrel but not ticlopidine produces an antiplatelet effect in the Yucatan minipig.
    Bostwick JS; Costanzo S; Byan L; Luo Y; Natarajan C; Bilder G
    Thromb Haemost; 2000 Nov; 84(5):928. PubMed ID: 11127885
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 16. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
    Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
    Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
    [No Abstract]   [Full Text] [Related]  

  • 18. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
    Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
    Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
    [No Abstract]   [Full Text] [Related]  

  • 19. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Alfonso F; Macaya C; Bass TA; Costa MA
    J Am Coll Cardiol; 2007 Apr; 49(14):1505-16. PubMed ID: 17418288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.